MAP7 and ovarian cancer: Subsequent evaluations, utilizing CCK-8 proliferation assays and colony formation tests, illustrated a marked decline in ovarian cancer cell proliferation post-MAP7 knockdown, substantiating the gene's contributory role to cell growth (Fig. 2D–F, and G).